General Information of Drug (ID: DMRQGMZ)

Drug Name
HD-003 Drug Info
Synonyms NZ-419; Selective hydroxy radical modulator (chronic kidney disease), Hyundai/ Nippon Zoki
Indication
Disease Entry ICD 11 Status REF
Kidney disease GC2Z Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMRQGMZ

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hydroxy radical elimination (HYRE) TT20DOQ NOUNIPROTAC Modulator [2]

References

1 ClinicalTrials.gov (NCT02378194) Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug. U.S. National Institutes of Health.
2 Creatinine and HMH (5-hydroxy-1-methylhydantoin, NZ-419) as intrinsic hydroxyl radical scavengers. Drug Discov Ther. 2011 Aug;5(4):162-75.